EPA:NRX Naturex (NRX) Stock Price, News & Analysis €134.40 0.00 (0.00%) As of 09/12/2018 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Naturex Stock (EPA:NRX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Naturex alerts:Sign Up Key Stats Today's Range€134.40▼€134.8050-Day Range€134.40▼€134.4052-Week Range N/AVolume516 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Naturex S.A. sources, produces, and sells natural ingredients for the food, health, and beauty sectors. The company offers various products for use in the food and beverage industries, including NAT color, a color solution; NAT stabil, an ingredient for food preservation; NAT healthy botanicals; IALIN thaumatin; NAT texture, a pectin for thickening, gelling, and stabilizing; NAT arom, natural flavoring ingredients; and NAT taste to enhance taste, as well as quillaia extracts under the UPTAIA and SAPNOV names. It also provides NAT fruits&greens, which are a range of vegetable and superfood powders that preserve raw material integrity for organoleptic and/or nutrition properties; NAT activ, a range of botanicals; NAT pharma, an active pharmaceutical ingredient for use in herbal medicines; and NAT life, a natural ingredient for use in the dietary supplement market. In addition, the company offers NAT select, a botanical extract; NAT oleis, a botanical oil; and NAT beauty, an active ingredient for use in personal care products. Further, it provides toll manufacturing services. The company was founded in 1992 and is headquartered in Avignon, France. As of September 3, 2018, Naturex S.A. operates as a subsidiary of Givaudan SA. Read More Receive NRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Naturex and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRX Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com NRX Stock Analysis - Frequently Asked Questions How have NRX shares performed this year? Naturex's stock was trading at €134.40 at the start of the year. Since then, NRX stock has increased by 0.0% and is now trading at €134.40. What other stocks do shareholders of Naturex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Naturex investors own include WD-40 (WDFC), Fomento Economico Mexicano (FMX), Ever-Glory International Group (EVK), ERShares Entrepreneurs ETF (ENTR), D.R. Horton (DHI), Dillard's (DDS) and Casella Waste Systems (CWST). Industry, Sector and Symbol Stock ExchangeEPA SectorConsumer Defensive Industry Packaged Foods Sub-IndustryN/A Current SymbolEPA:NRX CIKN/A Webwww.naturex.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (EPA:NRX) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThe Obscure Korean War Act That Created a $5.39 Billion Passive Income StreamAn obscure Korean War law has just been enacted by the U.S. government... Allowing it to take a heavy hand ...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Naturex S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Naturex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.